Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.
Saved in:
| Title: | Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study. |
|---|---|
| Authors: | Ferrante, Marc1 (AUTHOR) marc.ferrante@uzleuven.be, D'Haens, Geert2 (AUTHOR), Jairath, Vipul3 (AUTHOR), Danese, Silvio4 (AUTHOR), Chen, Minhu5 (AUTHOR), Ghosh, Subrata6 (AUTHOR), Hisamatsu, Tadakazu7 (AUTHOR), Kierkus, Jaroslaw8 (AUTHOR), Siegmund, Britta9 (AUTHOR), Bragg, Sonja Michelle10 (AUTHOR), Crandall, Wallace10 (AUTHOR), Durand, Frederick10 (AUTHOR), Hon, Emily10 (AUTHOR), Lin, Zhantao10 (AUTHOR), Lopes, Michelle Ugolini10 (AUTHOR), Morris, Nathan10 (AUTHOR), Protic, Marijana10 (AUTHOR), Carlier, Hilde10 (AUTHOR), Sands, Bruce E11 (AUTHOR) |
| Source: | Lancet. Dec2024, Vol. 404 Issue 10470, p2423-2436. 14p. |
| Database: | Business Source Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: bsu DbLabel: Business Source Ultimate An: 181574997 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Ferrante%2C+Marc%22">Ferrante, Marc</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> marc.ferrante@uzleuven.be</i><br /><searchLink fieldCode="AR" term="%22D'Haens%2C+Geert%22">D'Haens, Geert</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jairath%2C+Vipul%22">Jairath, Vipul</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Danese%2C+Silvio%22">Danese, Silvio</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Minhu%22">Chen, Minhu</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ghosh%2C+Subrata%22">Ghosh, Subrata</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hisamatsu%2C+Tadakazu%22">Hisamatsu, Tadakazu</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kierkus%2C+Jaroslaw%22">Kierkus, Jaroslaw</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Siegmund%2C+Britta%22">Siegmund, Britta</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bragg%2C+Sonja+Michelle%22">Bragg, Sonja Michelle</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Crandall%2C+Wallace%22">Crandall, Wallace</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Durand%2C+Frederick%22">Durand, Frederick</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hon%2C+Emily%22">Hon, Emily</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lin%2C+Zhantao%22">Lin, Zhantao</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lopes%2C+Michelle+Ugolini%22">Lopes, Michelle Ugolini</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Morris%2C+Nathan%22">Morris, Nathan</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Protic%2C+Marijana%22">Protic, Marijana</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Carlier%2C+Hilde%22">Carlier, Hilde</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sands%2C+Bruce+E%22">Sands, Bruce E</searchLink><relatesTo>11</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Lancet%22">Lancet</searchLink>. Dec2024, Vol. 404 Issue 10470, p2423-2436. 14p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=bsu&AN=181574997 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0140-6736(24)01762-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 14 StartPage: 2423 Titles: – TitleFull: Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ferrante, Marc – PersonEntity: Name: NameFull: D'Haens, Geert – PersonEntity: Name: NameFull: Jairath, Vipul – PersonEntity: Name: NameFull: Danese, Silvio – PersonEntity: Name: NameFull: Chen, Minhu – PersonEntity: Name: NameFull: Ghosh, Subrata – PersonEntity: Name: NameFull: Hisamatsu, Tadakazu – PersonEntity: Name: NameFull: Kierkus, Jaroslaw – PersonEntity: Name: NameFull: Siegmund, Britta – PersonEntity: Name: NameFull: Bragg, Sonja Michelle – PersonEntity: Name: NameFull: Crandall, Wallace – PersonEntity: Name: NameFull: Durand, Frederick – PersonEntity: Name: NameFull: Hon, Emily – PersonEntity: Name: NameFull: Lin, Zhantao – PersonEntity: Name: NameFull: Lopes, Michelle Ugolini – PersonEntity: Name: NameFull: Morris, Nathan – PersonEntity: Name: NameFull: Protic, Marijana – PersonEntity: Name: NameFull: Carlier, Hilde – PersonEntity: Name: NameFull: Sands, Bruce E IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 12 Text: Dec2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 01406736 Numbering: – Type: volume Value: 404 – Type: issue Value: 10470 Titles: – TitleFull: Lancet Type: main |
| ResultId | 1 |